Skip to content

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04749940
Enrollment
0
Registered
2021-02-11
Start date
2021-01-01
Completion date
2021-06-01
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of Skin Graft Donor Site

Brief summary

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial

Detailed description

A prospective single-blind study, where the evaluator is blinded to the treatment. Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PRF dressing, and half with Aquacel®. 3 days after surgery the patients will be asked to complete a VAS questionnaire. A week and 2 weeks after surgery, patients will have their dressing changed as in the first treatment, and will answer VAS(9) and bluebelle(10) questionnaires. The wound will be photographed again for follow-up. Three weeks, 6 weeks and 3 months after surgery the scar in the donor area will be evaluated. The photographs will be shown to the blinded evaluator, to evaluate wound healing by epithelialization estimation.

Interventions

OTHERHalf of the harvested area will be dressed with PRF dressing, and half with Aquacel®.

Half of the harvested area will be dressed with PRF dressing, and half with Aquacel®.

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PRF dressing, and half with Aquacel®. 3 days after surgery the patients will be asked to complete a VAS questionnaire. A week and 2 weeks after surgery, patients will have their dressing changed as in the first treatment, and will answer VAS(9) and bluebelle(10) questionnaires. The wound will be photographed again for follow-up. Three weeks, 6 weeks and 3 months after surgery the scar in the donor area will be evaluated. The photographs will be shown to the blinded evaluator, to evaluate wound healing by epithelialization estimation.

Intervention model description

A prospective single-blind study, where the evaluator is blinded to the treatment. Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PRF dressing, and half with Aquacel®.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients with a small burn (2-20% TBSA), who require skin grafting.

Exclusion criteria

* Patients younger than 18 years * Patients refusing hospitalization * Patients with heavily infected wounds, which are the probable cause of bacteremia or sepsis. * Patients with diabetes mellitus or peripheral vascular disease * Patients under treatment of steroids or other immunosuppressing agents * Patients with infectious diseases, i.e., HIV, HCV or HBV. * Patients who are smokers. * Patients with a known allergy to the dressing. * Female patients who are pregnant or nursing, psychiatric patients and soldiers.

Design outcomes

Primary

MeasureTime frameDescription
Change of percentage of wound healing after 1 week, 2 weeks and 3 weeks.3 weeksPrimary variables will be analyzed using ImageJ software.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026